Jiaying Pharmaceutical disclosed on May 14, 2024 in the Shenzhen Stock Exchange that as of May 10, 2024, the number of shareholders of the company was 23,400, an increase of 517 or 2.26% from the previous period (April 30, 2024).
The number of shareholders of Jiaying Pharmaceutical is lower than the industry average. According to Choice data, as of May 10, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 29.05%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 31, 2024, the number of shareholders of the company has increased, with an increase of 0.27%. From March 31, 2024 to May 10, 2024, the stock price decreased by 2.30%.
Number of shareholders and share price
Number of shareholders and share capital
As of May 10, 2024, the company's latest total share capital is 508 million shares, all of which are outstanding shares. The average number of outstanding shares held by households decreased from 22,200 shares in the previous period to 21,700 shares, and the average circulating market value of households was 138,200 yuan.
The average amount of shares held by each household
The market value of Jiaying Pharmaceutical's outstanding holdings is lower than the industry average. According to Choice data, as of May 10, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 402,300 yuan. Among them, 25.10% of the company's households hold a circulating stock market value of 130,000~250,000 yuan, and Jiaying Pharmaceutical is also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.